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Edited by B. HelmsAbstract Since their discovery and subsequent puriﬁcation
from mammalian tissues more than 30 years ago an impressive
number of studies have been carried out to characterize and elu-
cidate the biological functions of phosphatidylcholine transfer
protein (PC-TP), phosphatidylinositol transfer protein (PI-TP)
and non-speciﬁc lipid transfer protein, more commonly known
as sterol carrier protein 2 (SCP-2). Here I will present informa-
tion to show that these soluble, low-molecular weight proteins
constitute domain structures in StArR-related lipid transfer
(START) proteins (i.e. PC-TP), in retinal degeneration protein,
type B (RdgB)-related PI-TPs (e.g. Dm RdgB, Nir2, Nir3) and
in peroxisomal b-oxidation enzyme-related SCP-2 (i.e. 3-oxo-
acyl-CoA thiolase, also denoted as SCP-X and the 80-kDa D-
bifunctional protein). Further I will summarize the most recent
studies pertaining to the physiological function of these soluble
phospholipid transfer proteins in metazoa.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
Keywords: Phospholipid transfer proteins; PC-TP; PI-TP;
SCP-2; Cholesterol; Metazoa1. Introduction
Transfer and exchange of phospholipids and cholesterol was
initially observed in the serum between lipoproteins [1] as well
as between chylomicrons and lipoproteins [2]. Given the low
oﬀ-rate of these hydrophobic molecules at the lipid–water
interface this spontaneous lipid redistribution did not reﬂect
monomer transfer through the aqueous phase, but was inter-
preted to be due to collisions between particles. Apart from
this rather unspeciﬁc, non-mediated transfer it was subse-
quently shown that plasma contains lipid transfer proteins,
speciﬁcally cholesterol ester transfer protein (CETP) [3] and
phospholipid transfer protein (PLTP) [4] both acting as speciﬁc
mediators of lipid transfer between lipoproteins and lipopro-
teins and cells. CETP plays a key role in the conversion of very
low density lipoprotein (VLDL) into low density lipoprotein
(LDL) by replacing triglyceride for cholesterol ester. Among
other activities PLTP is intimately involved with the modiﬁca-Abbreviations: PC, phosphatidylcholine; PI, phosphatidylinositol;
SPM, sphingomyelin; PIP2, phosphatidylinositol 4,5-bisphosphate
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doi:10.1016/j.febslet.2006.06.065tion of high density lipoprotein (HDL) and the removal of
phospholipid and cholesterol from peripheral tissues by HDL.
Prior to the discovery of these plasma lipid transferring pro-
teins it was observed that the membrane-free cytosol from
mammalian tissues facilitated the transfer of phospholipids be-
tween subcellular organelles like mitochondria and micro-
somes [5]. In view of the experience with plasma lipoproteins
it was assumed that the cytosol also contained lipoprotein-like
structures which by collision with the organelles would give
rise to lipid exchange and, thereby, act as mediators of lipid
transfer between diﬀerent organelles. However, the cytosol de-
pleted from these cellular ‘lipoproteins’ kept its phospholipid
transfer activity providing the ﬁrst evidence that mammalian
cells may contain proteins that mediate phospholipid transfer
between membrane interfaces [6]. This observation has been
the starting point of extensive eﬀorts to purify these phospho-
lipid transfer proteins (PL-TPs) from mammalian sources [7].
To date, three diﬀerent classes of mammalian phospholipid
transfer proteins (PL-TPs) are known; (i) phosphatidylcholine
transfer protein (PC-TP), (ii) phosphatidylinositol transfer
protein (PI-TP) and (iii) the non-speciﬁc lipid transfer protein,
more commonly denoted as sterol carrier protein 2 (SCP-2)
which is able to transfer a wide range of phospholipids includ-
ing sterols. The 3D-structure of these proteins has been eluci-
dated showing that despite a lack of primary structure
homology, each protein has a hydrophobic cavity suited to
accommodate a speciﬁc lipid ligand [8–10]. The exposure of
this lipid binding site at the membrane interface is a prerequi-
site for these proteins to act as carriers of phospholipids and
cholesterol (in the case of SCP-2) between membranes. Ortho-
logues of PL-TPs have been identiﬁed in a great variety of
organisms among which zebra ﬁsh, Caenorhabditis elegans,
Drosophila melanogaster, yeast and plants. Despite many years
of research the biological role of these PL-TPs is still much of
an enigma. Here I will present the most current information on
how these PL-TPs relate to other proteins and what cellular
functions they may fulﬁll.2. Intracellular phospholipid transfer proteins and domain
structures
PC-TP. This 28-kDa protein is highly speciﬁc for phospha-
tidylcholine (PC) [11]. It belongs to the START (steroidogenic
acute regulatory protein related transfer) domain superfamily
of hydrophobic ligand-binding proteins. Since its 214-residue
amino acid sequence makes up the actual START domain,
PC-TP represents the minimal START protein structure. Inblished by Elsevier B.V. All rights reserved.
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at least another 30 human proteins among which the steroido-
genic MLN64, steroidogenic acute regulatory protein
(StAR), p122-Rho GTPase activating protein, Goodpasture
antigen-binding protein (GPBP) and a acyl-CoA thioesterase
(KIAA0707) [12]. From the superposition of the structures
known to date it is clear that the overall fold of PC-TP is sim-
ilar to the START domain of MLN64 [9]. On the other hand,
START domain proteins express diﬀerent lipid aﬃnities. StAR
and MLN64, both involved in steroidogenesis, bind and trans-
fer cholesterol [13], StarD10, a protein overexpressed in breast
cancer, binds and transfers PC and phosphatidylethanolamine
[14] whereas a splicing variant of GPBP is involved in the
intracellular traﬃcking of ceramide [15]. It is to be noted that
START proteins (e.g. PH domain proteins, RhoGAP proteins
and PC-TP-like proteins) are also found in C. elegans and in
Drosophila. An extensive family of START domain proteins
is present in plants the majority of which belong to a novel
class of putative lipid/sterol-binding homeodomain (HD) tran-
scription factors [16]. These HD-START proteins may provide
a mechanism by which lipid ligands can modulate transcrip-
tion in plants.
SCP-2. This 13.2-kDa basic protein is also known as non-
speciﬁc lipid transfer protein (nsL-TP) for reasons that
in vitro this protein lacks speciﬁcity facilitating the transfer
of sterols and a great variety of phospholipids between mem-
branes [17,18]. Extensive lipid binding studies emphasize the
non-speciﬁc character of SCP-2 in that the lipid binding cavity
can accommodate fatty acids, fatty acyl-CoA esters, PC, cho-
lesterol, dehydroergosterol as well as their ﬂuorescently labeled
analogues [19]. The mammalian SCP-2 domain constitutes the
C-terminal part of the 58-kDa peroxisomal 3-oxoacyl-CoA
thiolase, also denoted as SCP-X [20,21] and of the 80-kDa
D-bifunctional protein expressing 17b-hydroxysteroid
dehydrogenase, fatty acid-CoA dehydrogenase and fatty
acid-CoA hydratase activity [22]. Like SCP-2 either peroxi-
somal enzyme transfers 7-dehydrocholesterol and PC from
small unilamellar vesicles to acceptor membranes in vitro.
SCP-2 is formed by cleavage of SCP-X or from pre-SCP-2
both of which proteins are encoded by the gene SCP-X which
has two separate promoters [23]. Owing to the AKL peroxi-
somal targeting sequence both SCP-X and pre-SCP-2 are im-
ported into the peroxisomes by the Pex5p-mediated PTS1
pathway where these proteins are processed posttranslationally
[24]. Despite the presence of the PTS-1 targeting signal, sub-
stantial amounts of SCP-2 are found in the cytosol possibly
due to the modulation of the C-terminal PTS1, i.e. cleavage
of the leucine residue [19,24,25]. At this point it is not known
to what extent SCP-X and pre-SCP-2 contribute to the cyto-
solic SCP-2. On the other hand, overexpression of the cDNA
encoding the 58-kDa SCP-X in transfected mouse L-cell ﬁbro-
blasts provided clear evidence that apart from the peroxisomal
localization signiﬁcant amounts of SCP-X/SCP-2 were extra-
peroxisomal [26]. SCP-X carrying the SCP-2 domain is also
commonly expressed in insects (e.g. mosquito Aedes aegypti,
Drosophila melanogaster, cotton leafworm Spodoptera litto-
ralis). In the mosquito SCP-X was predominantly found in
peroxisomes and SCP-2 in the cytosol [27]. SCP-2 is also ex-
pressed in the peroxisomes of Arabidopsis thaliana being 54%
similar to human SCP-2 [28]. Similarly, a SCP-2 domain has
been detected at the carboxy-terminal end of UNC-24 a pro-
tein which is required for C. elegans to display normal locomo-tion [29]. It was suggested that this domain (64% similar to
human SCP-2) may be tethered to the plasma membrane by
the juxtaposed stomatin-like domain of UNC-24, and as such
could be involved in lipid transfer between closely apposed
membranes.
PI-TP. Mammalian cells express two soluble, 35-kDa PI-
TPs, i.e. PI-TPa and PI-TPb, which are highly homologous
(>98% sequence identity). Initially puriﬁed from bovine brain
cytosol, both isoforms act as carriers of phosphatidylinositol
(PI) and PC between membranes in vitro, yet PI-TPb can also
transfer sphingomyelin (SPM) [30,31]. Another soluble PI-
transferring protein is the 38-kDa retinal degeneration Bb
(MrdgBb) which consists of a PI-TP-like domain (41% identi-
cal to PI-TPa) and a small carboxy-terminal domain [32].
MrdgBb was identiﬁed by homology to the retinal degenera-
tion protein (type B) in Drosophila, denoted as Dm rdgB
[33]. Mammalian homologues of Dm RdgB are rdgB1 (Nir2)
(1244 amino acids) and rdgB2 (Nir3) (1349 amino acids) both
of which proteins carry an amino-terminal PI-TP domain and
a highly conserved carboxy-terminal segment containing the
tyrosine kinase Pyk2-binding domain [34]. The PI-TP domains
of Nir2 and Nir3 are 45% identical to PI-TPa, 72% identical
with each other and 65% identical with the Drosophila homo-
logue. Recently the genomic organization of both soluble and
membrane-associated Drosophila and human PI-TP-domain-
containing genes was determined [35]. Phylogenetic analysis
indicated that the gene lineage of PI-TPa and PI-TPb and
the membrane-associated Dm RdgB, Nir2 and Nir3 arose at
a very early stage in human evolution. Apart from Drosophila
[36], PI-TPs are also found in zebraﬁsh [37], C. elegans and
yeast [38] and as an amino-terminal domain of the COW1 pro-
tein in Arabidopsis [39]. It is to be noted that the COW1 PI-TP
domain is 32% identical to the yeast PI-TP (Sec14 protein)
which has neither sequence nor structural homology with
metazoan PI-TPs.3. PC-TP and phosphatidylcholine transport to the plasma
membrane
Initially it was proposed that PC-TP is involved in the trans-
fer of PC from its site of biosynthesis, the endoplasmic reticu-
lum, to other subcellular organelles deﬁcient in PC
biosynthesis [7,40]. Isotope labeling studies showed that the
translocation of newly synthesized PC to mitochondria and
plasma membrane in living cells was very rapid with a half-
time of equilibration of a few minutes, yet no conclusion could
be drawn as to whether PC-TP was responsible for this rapid
equilibration [41,42]. In view of its relatively high expression
in liver and lung type II cells it was proposed that PC-TP
may be involved in supplying PC to the canalicular membrane
for secretion into bile or the production of lung surfactant.
However, none of these functions appeared to be aﬀected in
Pc-tp/ mice [43]. Although disruption of the Pc-tp gene
did not aﬀect the output of PC, bile salts and cholesterol into
bile of Pc-tp/ mice fed a chow diet, the secretion of these bil-
iary components was impaired when these mice were fed a
high-fat, high-cholesterol lithogenic diet [44]. This may indi-
cate that under conditions of a dietary challenge PC-TP deﬁ-
ciency may result in a defect in the traﬃcking of the biliary
components to the canilicular membrane. Although the role
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dence indicates that PC-TP may participate in the regulation
of hepatic cholesterol homeostasis possibly at the level of acyl
CoA:cholesterol acyltransferase located in the endoplasmic
reticulum [45]. Another line of evidence suggests that PC-TP
is involved in the metabolism of HDL by modulating its par-
ticle size and rates of hepatic clearance in mice [46]. Moreover,
PC-TP overexpressed in Chinese hamster ovary cells appears
to contribute to the accelerated apolipoprotein A-1 (apoA-
1)-mediated lipid eﬄux possibly by replenishing the plasma
membrane with PC which becomes available during pre-b-
HDL particle formation via ATP binding cassette A1
(ABCA1) [47]. One of the important questions is whether
intracellular PC-TP activity is connected to HDL metabolism
as controlled by plasma PLTP activity. A main function of
plasma PLTP is the enlargement of HDL particles which is
accompanied by the release of lipid-poor apoA-1 [48]. PLTP
also plays a key role in the removal of excess cholesterol and
phospholipids from peripheral cells via ABCA1 by HDL apo-
lipoproteins [49,50]. These studies strongly suggest that the cel-
lular function of PC-TP may be intimately linked to plasma
PLTP activity. On the other hand, the lack of a clear pheno-
type in Pc-tp/ mice may indicate that other START proteins
(e.g. StarD7, StarD10 and Goodpasture antigen-binding pro-
tein) eﬀectively fulﬁll the function of PC-TP (also denoted as
StarD2) in these mice [12].4. SCP-2 in cholesterol and fatty acid metabolism
In view of the occurrence of SCP-2 both in the cytosol
and the peroxisomes it is reasonable to assume that these
two SCP-2 pools are involved in diﬀerent cellular processes.
There is ample evidence that cytosolic SCP-2 plays a role in
intracellular non-vesicular cholesterol transport to the plas-
ma membrane as well as in the cellular uptake of cholesterol
and fatty acids (for an extensive review, see [19]). As for
peroxisomal SCP-2 it appears likely that this protein is in-
volved in the peroxisomal b-oxidation of fatty acids possibly
by facilitating the presentation of substrates to the enzymes
involved. So it was shown that in situ SCP-2 was associated
with acyl-CoA oxidase, the 41-kDa 3-oxoacyl-CoA thiolase
(thiolase A) and bifunctional enzyme [25]. Based on
in vitro evidence it was also proposed that the association
of SCP-2 with the b-oxidation complex could be important
for the protection of unsaturated fatty acid intermediates
against oxidative attack by hydroxyl radicals generated in
the peroxisomes from H2O2 [51]. A role in the cellular de-
fense against oxidative damage is in line with SCP-2 and
SCP-X being upregulated by the daf-16-like Forkhead tran-
scription factor FOXO3a [51]. Previously these transcription
factors have been shown to protect against oxidative stress
by increasing the levels of the antioxidant enzymes MnSOD
and catalase [52]. In addition to thiolase A which is respon-
sible for the thiolytic cleavage of straight chain 3-oxoacyl-
CoAs, peroxisomes contain a 58-kDa thiolase (SCP-X)
which can be converted into a 46 kDa-thiolase by enzymatic
removal of the carboxy-terminal SCP-2 domain [53]. This
SCP-2/thiolase catalyzes the thiolytic cleavage of the 3-oxo-
acyl-CoA derivatives of the tetramethyl-branched chain pris-
tanic acid. In agreement with this function, phytanic acid,
the precursor of pristanic acid, accumulated 10-fold inSCP-2/SCP-X knockout mice [54]. Similarly, SCP-2/thiolase
is critical for the thiolytic cleavage step of the steroid side
chain of cholesterol as step in the conversion into bile acids
[55]. Accordingly, bile and serum of SCP-2/SCP-X knockout
mice displayed a pronounced accumulation of a characteris-
tic derivative of the 3a,7a,12a-trihydroxy-24 keto-cholesta-
noyl-CoA bile acid precursor, the putative substrate of the
SCP-2/thiolase. Subsequent studies on SCP-2/SCP-X knock-
out mice supported a role of SCP-2 in cholesterol metabo-
lism, biliary lipid secretion and intracellular cholesterol
distribution [56]. Recently, cytosolic SCP-2 was found to di-
rectly interact with caveolin-1, thereby fulﬁlling a function in
targeting, among other lipids, PI to caveolae at the cell sur-
face plasma membrane [57]. Given the long and winding
road to understanding SCP-2 function one may expect that
SCP-2 plays an intricate role in various aspects of intracel-
lular lipid metabolism still to be discovered.5. PI-TP is essential for intracellular signaling
The ability of PI-TPa and PI-TPb to speciﬁcally bind and
transfer PI and, be it with a lower aﬃnity, PC and SPM (only
PI-TPb) is intriguing for the fact that the metabolism of these
particular phospholipids is linked to lipid signaling pathways,
thereby raising the question to what extent PI-TPs play a role
in these pathways. In line with the hypothesis that PI-TP trans-
fers PI from intracellular stores to the plasma membrane as
part of the receptor-controlled phosphoinositide signaling
pathway [58] ample evidence is now available that addition
of PI-TPs to permeabilized cells stimulates the production of
inositol phosphates (for reviews, see [59,60]). In these reconsti-
tution studies PI-TPa and PI-TPb appear to be equally eﬀec-
tive. Given that PI-TPa localizes predominantly to the
nucleus and cytoplasm and PI-TPb to the Golgi complex
[61–63] one wonders how in situ this intracellular localization
can be reconciled with their proposed roles in phosphoinosi-
tide signaling at the plasma membrane. An explanation for this
anomaly becomes the more pressing as murine embryonic stem
(ES) cells deﬁcient in PI-TPa developed normally during
embryogenesis expressing all functions which were proposed
to require PI-TPa [64]. On the other hand, PI-TPb gene abla-
tion failed to give viable ES cells again emphasizing that PI-
TPa and PI-TPb fulﬁll diﬀerent cellular functions [64]. Very
interestingly, PI-TPa/ mice died early after birth stemming
from complicated organ failure including spinocerebellar dis-
ease, hypoglycemia and intestinal and hepatic steatosis [65].
At an earlier stage, the phenotype of the vibrator mouse was
found to be linked to a single mutation in intron 4 of the PI-
TPa gene [66]. In mice homozygous in the vibrator (vb) allele,
brain PI-TPa levels were ﬁvefold reduced. These mice dis-
played progressive action tremor and degeneration of neurons
in brain and spinal cord which led to early juvenile death.
Either of the above studies failed to provide a satisfactory
explanation as to why PI-TPa deﬁciency had such dire conse-
quences for the survival of the mice. Recently evidence was
provided that PI-TPa may be linked to the activation of a
PI-speciﬁc phospholipase A2 thereby being involved in the re-
lease of arachidonic acid and the subsequent production of an
eicosanoid-like factor(s), that stimulates cell growth and inhib-
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cultured primary neurons against induced cell death it was
proposed that the normal development of PI-TPa/ mice em-
bryos depended on a maternal supply of this factor lack of
which caused early death after birth [69]. In support of this
proposal, zebraﬁsh embryos microinjected at the one-cell stage
with PI-TPa-antisense oligonucleotides appeared to develop
normally, yet displayed a loss of spinal-cord neurons and de-
fects in motor-axon outgrowth [37]. In the latter study, how-
ever, this lack of axon outgrowth was interpreted to indicate
that netrin-1 which is an extracellular signal for neurite exten-
sion, requires PI-TPa for its activity. Similarly, the moderate
eﬀect of netrin-1 on neurite outgrowth in cortical explants
from homozygous vibrator mouse embryos (PI-TPavb mutant)
as compared to wild-type explants was thought to be due to a
lack of PI-TPa. This interpretation was based on the observa-
tion that netrin-1 was found to stimulate binding of PI-TPa to
the netrin receptor DCC (deleted in colorectal cancer) in cul-
tured mouse cortical neurons thereby increasing phospholipase
C-induced hydrolysis of phosphatidylinositol 4,5-bisphosphate
(PIP2). Increased PIP2 hydrolysis was not observed when
netrin-1 was added to cortical neurons isolated from homozy-
gous vibrator mice which are virtually devoid of PI-TPa.
Hence, it was concluded that PI-TPa is required for netrin-1
stimulated PIP2 hydrolysis thereby generating inositol phos-
phate signaling molecules which play an essential role in neu-
rite outgrowth [37].
Diﬀerent from mammals, Drosophila contains one soluble
PI-TP encoded by giotto (gio) [36]. This 35-kDa protein, de-
noted as Gio, is about 60% identical to mammalian PI-TPs,
yet based on phylogenetic analysis, Gio is closer to the b- than
to the a-isoform. Very interestingly, neuroblasts and spermat-
ocytes from gio mutants display cytokinesis failures. More-
over, evidence was obtained that Gio is involved in
membrane-vesicle fusion as gio mutations in spermatocytes
caused an abnormal accumulation of Golgi-derived vesicles.
A mammalian membrane-associated PI-TP-like protein,
Nir2, also plays an important role in membrane traﬃcking
and cytoskeletal remodeling [70]. By delivering PI to special-
ized membrane sites containing PI 4-kinase both Gio and
Nir2 are proposed to promote phosphatidylinositol 4-phos-
phate synthesis which would then lead to the formation of
PIP2, a lipid shown to be important in cytokinesis. Probably
inherent to the failure to properly carry out mitotic and mei-
otic cytokinesis, ablation of either the mouse PI-TPb (mamma-
lian Gio orthologue) or Nir2 gene resulted in early embryonic
death [64,71]. Recently, Nir2 was shown to be important for
maintaining a diacylglycerol (DAG) pool in the Golgi appara-
tus which is critical for controlling protein transport from the
trans-Golgi network to the plasma membrane [72]. In analogy
with yeast PI-TPb (Sec14p) it appears that Nir2 maintains the
Golgi DAG pool by regulating its consumption via the CDP-
choline pathway [73].
At this point many questions still remain on how PI-TPs
act in the cell. Do these proteins act by being targeted to
speciﬁc sites in the cell as proposed for the action of ne-
trin-1 [37] and/or do they then deliver substrates directly
to enzymes like PI 4-kinases and PI-speciﬁc phospholipase
A2 [74,75]? Another interesting suggestion is that by binding
either PI, PC or SPM, PI-TPs act as biosensors thereby reg-
ulating phospholipid metabolism at distinct sites in the cell
[73,76].6. Conclusion
The soluble PL-TPs (PC-TP, PI-TP, SCP-2) have the unique
property of being able to extract and bind a single lipid mole-
cule from a membrane interface. The importance of this fea-
ture is reﬂected in these PL-TPs being identiﬁed as domain
structures in a host of proteins, both soluble and membrane-
associated. As such these PL-TPs are involved in a wide variety
of essential cellular processes forming an interface between the
hydrophobic domain of the membrane and the enzymes/pro-
teins that need monomeric lipids for expressing their activity.
With genetic information available one is now able to map
PL-TPs in the total protein network which will undoubtedly
lead to new insights in how these proteins play key roles in cell
function.
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